Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0A6YN
|
||||
Former ID |
DIB016242
|
||||
Drug Name |
SUN-C5174
|
||||
Synonyms |
5-[3-[4-(4-Fluorophenyl)piperazin-1-yl]propyl]-8(S)-hydroxy-1-methyl-1,4,5,6,7,8-hexahydropyrrolo[3,2-c]azepin-4-one
|
||||
Indication | Peripheral vascular disease [ICD9: 443.9; ICD10:I73.9] | Discontinued in Phase 2 | [1] | ||
CAS Number |
CAS 191592-36-6
|
||||
Target and Pathway | |||||
Target(s) | 5-HT 2 receptor | Target Info | Antagonist | [2] | |
KEGG Pathway | Calcium signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Gap junction | |||||
Serotonergic synapse | |||||
Inflammatory mediator regulation of TRP channels | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800012828) | ||||
REF 2 | Synthesis and serotonin 2 (5-HT2) receptor antagonist activity of 5-aminoalkyl-substituted pyrrolo[3,2-c]azepines and related compounds. Chem Pharm Bull (Tokyo). 2000 May;48(5):623-35. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.